Deloitte Corporate Finance LLC Wins Health Care Deal of the Year Award from The M&A Advisor
NEW YORK, March 24, 2014 – Against the backdrop of a U.S. health industry undergoing intensive levels of convergence, Deloitte Corporate Finance LLC (“DCF”) has been named a winner of The M&A Advisor’s “Deal of the Year Award” in the healthcare/life sciences category.
DCF was recognized at The 8th Annual M&A Advisor Turnaround Awards for its advisory work regarding LMW Healthcare’s acquisition of the assets of Rhode Island-based The Westerly Hospital.
The M&A Advisor presented the honor March 11 in Palm Beach, Fla. Awards were given in 48 categories spanning a range of industries, size and other criteria. This year’s nominations involved more than 500 participating organizations judged by an independent panel of industry experts.
“We deeply appreciate this recognition, particularly in light of how critical M&A has become in health care,” said Simon Gisby, managing director, Deloitte Corporate Finance LLC. “This award acknowledges the value of our approach, which is to focus not just on assisting our clients in executing transactions but also on helping them with discerning opportunities from a strategic perspective as well as the hard work of blending different enterprises around process, technology and culture.”
David Fergusson, president of The M&A Advisor, commented that “DCF represents the best of the distressed investing and reorganization industry in 2013 and earned this honor by standing out in a group of very impressive candidates. Since 2002, we have been honoring the leading turnaround transactions, companies and dealmakers. DCF was chosen from more than 500 participating organizations. It gives us great pleasure to bestow upon DCF our highest honor for distressed investing and reorganization firms and professionals.”
Gisby noted that health care transactions are particularly dynamic in light of the industry’s fundamental shift to a new industry model, a system that focuses more on health outcomes and costs. To make this shift, he said, health organizations can be aided by new technologies and structures – including capabilities related to electronic health records, data analytics and personalized medicines – that enable them to improve clinical quality while becoming more efficient.
“For a health care organization today, it’s essential to have an end-to-end perspective when it comes to M&A, including the right strategic lens at the start and the ability to follow-through to facilitate the organization’s definition of a successful transaction,” said Gisby. “This award is gratifying in that it comes at a time when the outcome of a transaction is critical not just to the organization but to patients, the community and other stakeholders.”
Deloitte Corporate Finance LLC, a FINRA-registered broker-dealer, is an indirect wholly-owned subsidiary of Deloitte Financial Advisory Services LLP and affiliate of Deloitte Transactions and Business Analytics LLP. Deloitte Corporate Finance LLC provides deal execution and lead financial advisory services to large corporate, middle market, and private equity firms. Deloitte Corporate Finance has access to the resources of the Corporate Finance Advisory practices of the member firms (and their affiliates) within the Deloitte Touche Tohmatsu Limited network of member firms. Together with Deloitte Corporate Finance LLC, these practices include in excess of 1,600 professionals, working collaboratively in 150 international locations. Investment banking products and services within the United States are offered exclusively through Deloitte Corporate Finance LLC. For more information, visit www.investmentbanking.deloitte.com. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.
Prior engagement performance is no guarantee of future performance and may not be representative of the experience of other clients. This communication is for informational purposes only and is not intended as an offer or solicitation for the purchase or sale of a security.
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.